Author

Wendy A. Botwick

Observed name: Wendy Botwick

Observed institution: San Francisco State University

OpenAlex ID: A5069201220

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

2009 · Jason A. Tye-Din, Robert P. Anderson, et al. · Clinical Immunology · 156

Safety, Tolerability, and Activity of ALV003: Results from Two Phase 1 Single, Escalating-Dose Clinical Trials

2011 · Matthew Siegel, Mitchell E. Garber, et al. · Digestive Diseases and Sciences · 114

7:423. Oral REN-1654 in Sciatica: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study in Subjects With Pain Due to Lumbosacral Radiculopathy

2006 · Eugene J. Carragee, Jack A. Klapper, et al. · The Spine Journal · 3

191 ALV003, a Combination Oral Protease, Is Active, Safe and Tolerable in Healthy Volunteers and Subjects with Celiac Disease in Phase 1 Trials

2009 · Mitchell Garber, Matthew Siegel, et al. · Gastroenterology

Works count: 4

Citation count: 273

H-index: 3

I10-index: 2